Hongming Chen is an American chemical engineer.
Chen earned a Bachelor's of Science degree in chemical engineering from the University of Texas at Austin in 1992, and completed a Master's and Doctor of Science in the same subject at the Massachusetts Institute of Technology. She then conducted research at Merck & Co. and AstraZeneca. She later helped establish TransForm Pharmaceuticals, which was later acquired by Johnson & Johnson, and subsequently worked for Kala Pharmaceuticals from its founding in 2010, then cofounded Metis Therapeutics.
In 2015, Chen was elected a fellow of the American Institute for Medical and Biological Engineering. She was elected to membership of the United States National Academy of Engineering in 2018.
References
- "Five Alumni Honored with Cockrell School Distinguished Graduate Awards for 2021". University of Texas at Austin. 13 September 2022. Retrieved 16 October 2023.
- "Hongming Chen, Ph.D. To be Inducted into Medical and Biological Engineering Elite". American Institute for Medical and Biological Engineering. 12 March 2015. Retrieved 16 October 2023.
- "HONGMING CHEN, PH.D." American Institute for Medical and Biological Engineering. Retrieved 16 October 2023.
- "Dr. Hongming Chen". United States National Academy of Engineering. Retrieved 16 October 2023.
This biographical article about an American chemist is a stub. You can help Misplaced Pages by expanding it. |
This article about a United States engineer, inventor or industrial designer is a stub. You can help Misplaced Pages by expanding it. |
- Living people
- 21st-century American engineers
- 20th-century American engineers
- American women engineers
- American chemical engineers
- Massachusetts Institute of Technology alumni
- University of Texas at Austin alumni
- Members of the United States National Academy of Engineering
- Fellows of the American Institute for Medical and Biological Engineering
- AstraZeneca people
- Merck & Co. people
- Janssen Pharmaceutica people
- American chemist stubs
- American engineer stubs